NPORT-EX 2 QTLY_127_20220430.htm 010 - Quarterly Front Cover
Quarterly Holdings Report
for
Fidelity® Growth & Income Portfolio
April 30, 2022
GAI-NPRT3-0622
1.800339.118
Common Stocks - 96.9%
 
 
Shares
Value ($)
(000s)
 
COMMUNICATION SERVICES - 5.4%
 
 
 
Diversified Telecommunication Services - 0.8%
 
 
 
Cellnex Telecom SA (a)
 
441,500
20,578
Elisa Corp. (A Shares)
 
113,800
6,671
Verizon Communications, Inc.
 
767,174
35,520
 
 
 
62,769
Entertainment - 1.7%
 
 
 
Activision Blizzard, Inc.
 
168,450
12,735
Nintendo Co. Ltd. ADR
 
324,900
18,513
The Walt Disney Co. (b)
 
457,090
51,025
Universal Music Group NV
 
1,733,800
40,235
Warner Music Group Corp. Class A
 
383,200
11,408
 
 
 
133,916
Media - 2.9%
 
 
 
Comcast Corp. Class A
 
4,240,412
168,599
Interpublic Group of Companies, Inc.
 
1,592,431
51,945
 
 
 
220,544
TOTAL COMMUNICATION SERVICES
 
 
417,229
CONSUMER DISCRETIONARY - 2.8%
 
 
 
Auto Components - 0.5%
 
 
 
BorgWarner, Inc.
 
1,058,552
38,986
Hotels, Restaurants & Leisure - 0.6%
 
 
 
Churchill Downs, Inc.
 
100,200
20,335
Marriott International, Inc. Class A
 
109,923
19,514
Starbucks Corp.
 
143,260
10,693
 
 
 
50,542
Household Durables - 0.4%
 
 
 
Sony Group Corp. sponsored ADR
 
128,714
11,076
Whirlpool Corp. (c)
 
116,094
21,073
 
 
 
32,149
Specialty Retail - 1.2%
 
 
 
Lowe's Companies, Inc.
 
453,314
89,634
Williams-Sonoma, Inc.
 
11,200
1,461
 
 
 
91,095
Textiles, Apparel & Luxury Goods - 0.1%
 
 
 
Puma AG
 
90,754
6,678
Tapestry, Inc.
 
3,700
122
 
 
 
6,800
TOTAL CONSUMER DISCRETIONARY
 
 
219,572
CONSUMER STAPLES - 7.3%
 
 
 
Beverages - 2.4%
 
 
 
Diageo PLC sponsored ADR
 
216,911
43,096
Keurig Dr. Pepper, Inc.
 
963,300
36,027
Pernod Ricard SA
 
62,400
12,878
Remy Cointreau SA
 
36,314
7,199
The Coca-Cola Co.
 
1,381,910
89,285
 
 
 
188,485
Food & Staples Retailing - 1.3%
 
 
 
Alimentation Couche-Tard, Inc. Class A (multi-vtg.)
 
44,400
1,977
Sysco Corp.
 
770,536
65,865
Walmart, Inc.
 
194,400
29,741
 
 
 
97,583
Food Products - 0.3%
 
 
 
Lamb Weston Holdings, Inc.
 
332,360
21,969
Household Products - 0.3%
 
 
 
Colgate-Palmolive Co.
 
62,300
4,800
Kimberly-Clark Corp.
 
12,500
1,735
Spectrum Brands Holdings, Inc.
 
228,683
19,454
 
 
 
25,989
Tobacco - 3.0%
 
 
 
Altria Group, Inc.
 
3,525,967
195,938
Swedish Match Co. AB
 
4,325,800
34,454
 
 
 
230,392
TOTAL CONSUMER STAPLES
 
 
564,418
ENERGY - 11.6%
 
 
 
Oil, Gas & Consumable Fuels - 11.6%
 
 
 
Canadian Natural Resources Ltd.
 
514,415
31,838
Cenovus Energy, Inc. (Canada)
 
5,648,273
104,423
Enterprise Products Partners LP
 
103,500
2,682
Exxon Mobil Corp.
 
5,848,099
498,551
Hess Corp. (d)
 
1,288,764
132,833
Imperial Oil Ltd.
 
511,826
25,770
Kosmos Energy Ltd. (b)
 
4,191,075
28,332
Phillips 66 Co.
 
251,087
21,784
Tourmaline Oil Corp.
 
887,600
45,712
 
 
 
891,925
FINANCIALS - 16.4%
 
 
 
Banks - 11.7%
 
 
 
Bank of America Corp.
 
6,305,936
224,996
JPMorgan Chase & Co.
 
530,875
63,365
M&T Bank Corp.
 
119,194
19,862
PNC Financial Services Group, Inc.
 
538,301
89,412
Truist Financial Corp.
 
1,395,932
67,493
U.S. Bancorp
 
1,053,237
51,145
Wells Fargo & Co.
 
8,748,970
381,718
 
 
 
897,991
Capital Markets - 3.1%
 
 
 
Ashmore Group PLC
 
1,225,000
3,386
Brookfield Asset Management, Inc. Class A
 
300,902
15,003
Intercontinental Exchange, Inc.
 
12,600
1,459
KKR & Co. LP
 
505,852
25,783
Morgan Stanley
 
342,151
27,574
Northern Trust Corp.
 
787,853
81,188
Raymond James Financial, Inc.
 
406,570
39,624
S&P Global, Inc.
 
1,100
414
State Street Corp.
 
666,591
44,642
 
 
 
239,073
Consumer Finance - 0.3%
 
 
 
Discover Financial Services
 
188,168
21,161
Insurance - 1.0%
 
 
 
American Financial Group, Inc.
 
40,800
5,650
Brookfield Asset Management Reinsurance Partners Ltd.
 
2,086
105
Chubb Ltd.
 
120,356
24,847
Marsh & McLennan Companies, Inc.
 
162,070
26,207
Old Republic International Corp.
 
213,800
4,706
The Travelers Companies, Inc.
 
82,627
14,134
 
 
 
75,649
Thrifts & Mortgage Finance - 0.3%
 
 
 
Essent Group Ltd.
 
249,123
10,097
Radian Group, Inc.
 
748,968
16,020
 
 
 
26,117
TOTAL FINANCIALS
 
 
1,259,991
HEALTH CARE - 14.2%
 
 
 
Biotechnology - 0.1%
 
 
 
Intercept Pharmaceuticals, Inc. (b)
 
230,704
3,624
Health Care Equipment & Supplies - 1.5%
 
 
 
Abbott Laboratories
 
42,500
4,824
Becton, Dickinson & Co.
 
102,086
25,235
Boston Scientific Corp. (b)
 
1,274,696
53,677
GN Store Nord A/S
 
48,000
1,801
Koninklijke Philips Electronics NV (depositary receipt) (NY Reg.)
 
811,545
20,922
Sonova Holding AG
 
24,692
8,905
 
 
 
115,364
Health Care Providers & Services - 5.9%
 
 
 
Cardinal Health, Inc.
 
781,711
45,378
Cigna Corp.
 
372,154
91,840
CVS Health Corp.
 
845,512
81,279
Humana, Inc.
 
37,100
16,493
McKesson Corp. (d)
 
321,134
99,426
UnitedHealth Group, Inc.
 
238,387
121,232
 
 
 
455,648
Life Sciences Tools & Services - 0.2%
 
 
 
Danaher Corp.
 
73,603
18,484
Pharmaceuticals - 6.5%
 
 
 
Bayer AG
 
1,104,335
72,744
Bristol-Myers Squibb Co. (d)
 
1,992,536
149,978
Eli Lilly & Co.
 
85,448
24,962
GlaxoSmithKline PLC sponsored ADR
 
1,998,911
90,511
Johnson & Johnson
 
616,089
111,179
Sanofi SA sponsored ADR
 
329,697
17,227
UCB SA
 
248,600
28,259
Viatris, Inc.
 
86,400
893
 
 
 
495,753
TOTAL HEALTH CARE
 
 
1,088,873
INDUSTRIALS - 15.1%
 
 
 
Aerospace & Defense - 2.8%
 
 
 
Airbus Group NV
 
339,400
37,155
General Dynamics Corp.
 
138,461
32,750
Huntington Ingalls Industries, Inc.
 
103,184
21,951
MTU Aero Engines AG
 
51,500
10,386
Raytheon Technologies Corp.
 
189,325
17,969
Safran SA
 
117,300
12,598
The Boeing Co. (b)
 
553,500
82,383
 
 
 
215,192
Air Freight & Logistics - 1.9%
 
 
 
DSV A/S
 
37,500
6,148
Expeditors International of Washington, Inc.
 
8,400
832
FedEx Corp.
 
106,674
21,200
United Parcel Service, Inc. Class B
 
649,199
116,843
 
 
 
145,023
Airlines - 0.0%
 
 
 
Copa Holdings SA Class A (b)
 
30,400
2,291
Building Products - 0.4%
 
 
 
A.O. Smith Corp.
 
90,600
5,294
Johnson Controls International PLC
 
387,611
23,206
 
 
 
28,500
Commercial Services & Supplies - 0.6%
 
 
 
GFL Environmental, Inc.
 
1,016,600
30,625
Healthcare Services Group, Inc. (c)
 
704,598
12,042
Ritchie Bros. Auctioneers, Inc.
 
15,600
859
 
 
 
43,526
Electrical Equipment - 1.0%
 
 
 
Acuity Brands, Inc.
 
137,915
23,788
Hubbell, Inc. Class B
 
130,472
25,489
Regal Rexnord Corp.
 
21,000
2,672
Rockwell Automation, Inc.
 
19,318
4,881
Vertiv Holdings Co.
 
1,544,000
19,346
 
 
 
76,176
Industrial Conglomerates - 4.7%
 
 
 
3M Co.
 
121,466
17,518
General Electric Co.
 
4,587,011
341,962
 
 
 
359,480
Machinery - 1.8%
 
 
 
Allison Transmission Holdings, Inc.
 
287,900
10,779
Caterpillar, Inc.
 
35,023
7,374
Cummins, Inc.
 
54,176
10,250
Donaldson Co., Inc.
 
619,612
30,386
Epiroc AB (A Shares)
 
32,700
663
Flowserve Corp.
 
342,178
11,193
Fortive Corp.
 
273,088
15,703
Kardex AG
 
6,600
1,256
Nordson Corp.
 
99,127
21,381
Otis Worldwide Corp.
 
87,573
6,379
PACCAR, Inc.
 
89,500
7,433
Stanley Black & Decker, Inc.
 
54,118
6,502
Westinghouse Air Brake Tech Co.
 
136,847
12,304
 
 
 
141,603
Professional Services - 0.5%
 
 
 
Equifax, Inc.
 
58,223
11,850
RELX PLC (London Stock Exchange)
 
842,858
25,109
Robert Half International, Inc.
 
9,500
934
 
 
 
37,893
Road & Rail - 0.5%
 
 
 
Knight-Swift Transportation Holdings, Inc. Class A
 
785,909
37,637
Trading Companies & Distributors - 0.8%
 
 
 
Brenntag SE
 
64,600
4,985
Fastenal Co.
 
126,376
6,990
MSC Industrial Direct Co., Inc. Class A
 
7,200
597
Watsco, Inc.
 
197,991
52,820
 
 
 
65,392
Transportation Infrastructure - 0.1%
 
 
 
Aena SME SA (a)(b)
 
49,200
6,982
TOTAL INDUSTRIALS
 
 
1,159,695
INFORMATION TECHNOLOGY - 19.1%
 
 
 
Electronic Equipment & Components - 0.2%
 
 
 
CDW Corp.
 
105,964
17,291
IT Services - 4.5%
 
 
 
Amadeus IT Holding SA Class A (b)
 
560,200
35,104
DXC Technology Co. (b)
 
112,900
3,240
Edenred SA
 
739,800
37,154
Fidelity National Information Services, Inc.
 
466,232
46,227
Genpact Ltd.
 
510,371
20,553
Global Payments, Inc.
 
118,400
16,218
IBM Corp.
 
196,242
25,945
MasterCard, Inc. Class A
 
33,667
12,234
Unisys Corp. (b)
 
805,430
11,445
Visa, Inc. Class A
 
626,375
133,499
 
 
 
341,619
Semiconductors & Semiconductor Equipment - 3.4%
 
 
 
Analog Devices, Inc.
 
153,108
23,637
Applied Materials, Inc.
 
139,500
15,394
Intel Corp.
 
699,316
30,483
Lam Research Corp.
 
27,430
12,776
Marvell Technology, Inc.
 
395,500
22,971
NXP Semiconductors NV
 
208,226
35,586
Qualcomm, Inc.
 
808,672
112,963
Teradyne, Inc.
 
78,000
8,226
 
 
 
262,036
Software - 7.5%
 
 
 
Intuit, Inc.
 
32,000
13,400
Microsoft Corp.
 
1,755,482
487,181
Open Text Corp.
 
165,128
6,613
SAP SE sponsored ADR
 
577,945
58,257
Temenos Group AG
 
116,330
11,743
 
 
 
577,194
Technology Hardware, Storage & Peripherals - 3.5%
 
 
 
Apple, Inc. (d)
 
1,629,112
256,830
FUJIFILM Holdings Corp.
 
62,600
3,441
Samsung Electronics Co. Ltd.
 
162,180
8,597
 
 
 
268,868
TOTAL INFORMATION TECHNOLOGY
 
 
1,467,008
MATERIALS - 2.6%
 
 
 
Chemicals - 0.7%
 
 
 
DuPont de Nemours, Inc.
 
704,198
46,428
PPG Industries, Inc.
 
73,722
9,436
 
 
 
55,864
Metals & Mining - 1.9%
 
 
 
First Quantum Minerals Ltd.
 
1,300,500
37,284
Freeport-McMoRan, Inc.
 
1,891,412
76,697
Glencore Xstrata PLC
 
5,368,200
33,077
 
 
 
147,058
TOTAL MATERIALS
 
 
202,922
REAL ESTATE - 1.1%
 
 
 
Equity Real Estate Investment Trusts (REITs) - 1.1%
 
 
 
American Tower Corp.
 
140,978
33,979
Equinix, Inc.
 
1,100
791
Public Storage
 
2,400
892
Simon Property Group, Inc.
 
399,860
47,183
 
 
 
82,845
UTILITIES - 1.3%
 
 
 
Electric Utilities - 1.2%
 
 
 
Constellation Energy Corp.
 
47,813
2,831
Duke Energy Corp.
 
116,721
12,858
Entergy Corp.
 
134,863
16,028
Exelon Corp.
 
143,440
6,710
PG&E Corp. (b)
 
663,900
8,398
Southern Co.
 
579,266
42,512
 
 
 
89,337
Multi-Utilities - 0.1%
 
 
 
Sempra Energy
 
68,596
11,069
TOTAL UTILITIES
 
 
100,406
 
TOTAL COMMON STOCKS
 (Cost $5,159,833)
 
 
 
7,454,884
 
 
 
 
Convertible Preferred Stocks - 0.3%
 
 
Shares
Value ($)
(000s)
 
HEALTH CARE - 0.3%
 
 
 
Health Care Equipment & Supplies - 0.3%
 
 
 
Becton, Dickinson & Co. 6.50%
 
154,800
7,839
Boston Scientific Corp. Series A, 5.50%
 
92,400
10,356
 
TOTAL CONVERTIBLE PREFERRED STOCKS
 (Cost $16,980)
 
 
 
18,195
 
 
 
 
Convertible Bonds - 0.1%
 
 
Principal
Amount (e)
(000s)
 
Value ($)
(000s)
 
HEALTH CARE - 0.1%
 
 
 
Biotechnology - 0.1%
 
 
 
Intercept Pharmaceuticals, Inc. 2% 5/15/26
 
  (Cost $10,523)
 
 
13,148
7,923
 
 
 
 
Other - 0.1%
 
 
Shares
Value ($)
(000s)
 
Other - 0.1%
 
 
 
Utica Shale Drilling Program (non-operating revenue interest) (f)(g)(h)
  (Cost $17,762)
 
13,918,119
6,022
 
 
 
 
Money Market Funds - 2.9%
 
 
Shares
Value ($)
(000s)
 
Fidelity Cash Central Fund 0.32% (i)
 
201,527,702
201,568
Fidelity Securities Lending Cash Central Fund 0.32% (i)(j)
 
23,599,515
23,602
 
TOTAL MONEY MARKET FUNDS
 (Cost $225,170)
 
 
225,170
 
 
 
 
 
TOTAL INVESTMENT IN SECURITIES - 100.3%
 (Cost $5,430,268)
 
 
 
7,712,194
NET OTHER ASSETS (LIABILITIES) - (0.3)%  
(20,644)
NET ASSETS - 100.0%
7,691,550
 
 
 Written Options
 
Counterparty
Number
of Contracts
Notional
Amount ($)
 
(000s)
Exercise
Price ($)
Expiration
Date
Value ($)
 
(000s)
Call Options
 
 
 
 
 
 
Apple, Inc.
Chicago Board Options Exchange
819
12,912
180.00
05/20/22
(22)
Bristol-Myers Squibb Co.
Chicago Board Options Exchange
1,937
14,580
77.00
05/20/22
(141)
Hess Corp.
Chicago Board Options Exchange
596
6,143
115.00
05/20/22
(64)
McKesson Corp.
Chicago Board Options Exchange
298
9,226
320.00
05/20/22
(155)
 
 
 
 
 
 
 
TOTAL WRITTEN OPTIONS
 
 
 
 
 
(382)
 
 
Any values shown as $0 in the Schedule of Investments may reflect amounts less than $500.
 
Legend
 
(a)
Security exempt from registration under Rule 144A of the Securities Act of 1933.  These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $27,560,000 or 0.4% of net assets.
 
(b)
Non-income producing
 
(c)
Security or a portion of the security is on loan at period end.
 
(d)
Security or a portion of the security is pledged as collateral for call options written. At period end, the value of securities pledged amounted to $42,861,000.
 
(e)
Amount is stated in United States dollars unless otherwise noted.
 
(f)
Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.
 
(g)
Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues).  At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $6,022,000 or 0.1% of net assets.
 
(h)
Level 3 security
 
(i)
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
 
(j)
Investment made with cash collateral received from securities on loan.
 
 
 
Additional information on each restricted holding is as follows:
Security
Acquisition Date
Acquisition Cost ($)
(000s)
Utica Shale Drilling Program (non-operating revenue interest)
10/05/16 - 12/16/20
17,762
 
Affiliated Central Funds
 
Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.
 
 
Affiliate (Amounts in thousands)
Value,
beginning
of period ($)
Purchases ($)
Sales
Proceeds ($)
Dividend
Income ($)
Realized
Gain (loss) ($)
Change in
Unrealized
appreciation
(depreciation) ($)
Value,
end
of period ($)
%ownership,
end
of period
Fidelity Cash Central Fund 0.32%
13,016
609,364
420,812
97
-
-
201,568
0.4%
Fidelity Securities Lending Cash Central Fund 0.32%
105,352
230,720
312,470
4,157
-
-
23,602
0.1%
Total
118,368
840,084
733,282
4,254
-
-
225,170
 
 
Amounts in the income column in the above table include any capital gain distributions from underlying funds.
 
Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.
 
 
Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee.   
 
The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:
 
Level 1 - Unadjusted quoted prices in active markets for identical investments
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)
 
Valuation techniques used to value investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For any foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
 
Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing vendors or from brokers who make markets in such securities. Convertible Bonds are valued by pricing vendors who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing vendors. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.
 
Exchange-traded options are valued using the last sale price or, in the absence of a sale, the last offering price and are categorized as Level 1 in the hierarchy.
 
Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
 
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.
 
Derivative Instruments
Risk Exposures and the Use of Derivative Instruments: The Fund's investment objectives allow the Fund to enter into various types of derivative contracts. Derivatives are investments whose value is primarily derived from underlying assets, indices or reference rates and may be transacted on an exchange or over-the-counter (OTC). Derivatives may involve a future commitment to buy or sell a specified asset based on specified terms, to exchange future cash flows at periodic intervals based on a notional principal amount, or for one party to make one or more payments upon the occurrence of specified events in exchange for periodic payments from the other party.
 
The Fund used derivatives to increase returns, to gain exposure to certain types of assets and/or to manage exposure to certain risks as defined below. The success of any strategy involving derivatives depends on analysis of numerous economic factors, and if the strategies for investment do not work as intended, the Fund may not achieve its objectives.  
 
The Fund's use of derivatives increased or decreased its exposure to the following risk(s):
 
Equity Risk - Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment.
 
Investing in derivatives may involve greater risks than investing in the underlying assets directly and, to varying degrees, may involve risk of loss in excess of any initial investment and collateral received. In addition, there may be the risk that the change in value of the derivative contract does not correspond to the change in value of the underlying instrument.  
 
Options: Options give the purchaser the right, but not the obligation, to buy (call) or sell (put) an underlying security or financial instrument at an agreed exercise or strike price between or on certain dates. Options obligate the seller (writer) to buy (put) or sell (call) an underlying instrument at the exercise or strike price or cash settle an underlying derivative instrument if the holder exercises the option on or before the expiration date.
 
The Fund used exchange-traded options to manage its exposure to the stock market.
 
Open options at period end are presented in the Schedule of Investments under the captions "Purchased Options," "Purchased Swaptions," "Written Options" and "Written Swaptions." Writing puts and buying calls tend to increase exposure to the underlying instrument while buying puts and writing calls tend to decrease exposure to the underlying instrument. For purchased options, risk of loss is limited to the premium paid, and for written options, risk of loss is the change in value in excess of the premium received.
 
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.
 
The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.
 
Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.